A COG Soft Tissue Sarcoma Biology and Banking Protocol

S
Sandeep Batra, MD

Primary Investigator

Administratively Closed
50 years - 100 years
All
Phase N/A
2 Locations

Brief description of study

What is the purpose of this study?

The purpose of this study is to collect and store tumor tissue, blood, and bone marrow samples from patients with soft tissue sarcoma that will be tested in the laboratory. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients to test in the laboratory may help the study of cancer.

THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic. 
 
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?

Surgical tissue, bone marrow, and blood specimens are collected at diagnosis (initial or relapse) and, if applicable, at the development of a second primary tumor. Specimens are used for research purposes. A certificate of confidentiality protecting the identity of research participants in this project has been issued by the National Cancer Institute.

Patients who are not enrolled on a Children's Oncology Group treatment trial are followed every 6 months for at least 10 years or until disease progression or development of a second malignancy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Sarcoma, Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma
  • Age: 50 years - 100 years
  • Gender: All

Inclusion Criteria
Diagnosed with one of the following: Rhabdomyosarcoma (RMS), Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS), Unclassified soft tissue sarcoma

Additional Information:

Participants will not be paid for their participation.
 

Updated on 05 Dec 2024. Study ID: PHO-COG-FALLON-D9902, 1010002653

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team